| 1 |
35173547 | HJURP Promotes Malignant Progression and Mediates Sensitivity to Cisplatin and WEE1-inhibitor in Serous Ovarian Cancer. | 2022 |
1 |
| 2 |
35626088 | Preclinical Head and Neck Squamous Cell Carcinoma Models for Combined Targeted Therapy Approaches. | 2022 May 18 |
1 |
| 3 |
34204834 | Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines. | 2021 Jun 12 |
2 |
| 4 |
34232919 | Antiparasitic mebendazole (MBZ) effectively overcomes cisplatin resistance in human ovarian cancer cells by inhibiting multiple cancer-associated signaling pathways. | 2021 Jul 7 |
1 |
| 5 |
34769137 | PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study. | 2021 Oct 28 |
1 |
| 6 |
34948122 | New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors. | 2021 Dec 11 |
2 |
| 7 |
35070983 | Prediction of the Mechanisms by Which Quercetin Enhances Cisplatin Action in Cervical Cancer: A Network Pharmacology Study and Experimental Validation. | 2021 |
1 |
| 8 |
31765939 | Glutamine deprivation counteracts hypoxia-induced chemoresistance. | 2020 Jan |
1 |
| 9 |
31821542 | Cisplatin-mediated down-regulation of miR-145 contributes to up-regulation of PD-L1 via the c-Myc transcription factor in cisplatin-resistant ovarian carcinoma cells. | 2020 Apr |
1 |
| 10 |
32319562 | Although c‑MYC contributes to tamoxifen resistance, it improves cisplatin sensitivity in ER‑positive breast cancer. | 2020 Apr |
3 |
| 11 |
32626933 | High expression of FUSE binding protein 1 in breast cancer stimulates cell proliferation and diminishes drug sensitivity. | 2020 Aug |
2 |
| 12 |
32710593 | Pluripotency transcription factor Nanog and its association with overall oral squamous cell carcinoma progression, cisplatin-resistance, invasion and stemness acquisition. | 2020 Nov |
1 |
| 13 |
32725721 | Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin. | 2020 Aug |
1 |
| 14 |
33089188 | Potential Role of DEC1 in Cervical Cancer Cells Involving Overexpression and Apoptosis. | 2020 Mar |
1 |
| 15 |
33488948 | Novel strategies to target chemoresistant triple-negative breast cancer. | 2020 Dec 31 |
1 |
| 16 |
30166592 | miR-137 mediates the functional link between c-Myc and EZH2 that regulates cisplatin resistance in ovarian cancer. | 2019 Jan |
7 |
| 17 |
30210134 | Gemcitabine, Dexamethasone, and Cisplatin Regimen as an Effective Salvage Therapy for High-grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements. | 2019 Feb 15 |
1 |
| 18 |
30668336 | Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression. | 2019 Mar 15 |
2 |
| 19 |
30825244 | c-Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T-cell lymphoma. | 2019 Aug |
4 |
| 20 |
31186712 | Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma in vitro and in vivo. | 2019 Jun |
1 |
| 21 |
31432162 | Cisplatin decreases cyclin D2 expression via upregulating miR‑93 to inhibit lung adenocarcinoma cell growth. | 2019 Oct |
1 |
| 22 |
31632022 | Exosomal Transfer Of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance In NSCLC Through Activating Autophagy. | 2019 |
1 |
| 23 |
31727874 | Cisplatin exposure causes c-Myc-dependent resistance to CDK4/6 inhibition in HPV-negative head and neck squamous cell carcinoma. | 2019 Nov 14 |
5 |
| 24 |
31761897 | Forkhead Box R2 Knockdown Decreases Chemoresistance to Cisplatin via MYC Pathway in Bladder Cancer. | 2019 Nov 25 |
2 |
| 25 |
31933859 | Silencing long non-coding RNA NEAT1 enhances the suppression of cell growth, invasion, and apoptosis of bladder cancer cells under cisplatin chemotherapy. | 2019 |
1 |
| 26 |
29257330 | Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc. | 2018 Mar |
2 |
| 27 |
29286162 | GC7 enhances cisplatin sensitivity via STAT3 signaling pathway inhibition and eIF5A2 inactivation in mesenchymal phenotype oral cancer cells. | 2018 Mar |
2 |
| 28 |
30071534 | HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response. | 2018 |
5 |
| 29 |
30443189 | Effect of RIF1 on response of non-small-cell lung cancer patients to platinum-based chemotherapy by regulating MYC signaling pathway. | 2018 |
4 |
| 30 |
28076844 | Sulforaphane inhibits cancer stem-like cell properties and cisplatin resistance through miR-214-mediated downregulation of c-MYC in non-small cell lung cancer. | 2017 Feb 14 |
2 |
| 31 |
28590415 | The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance. | 2017 Jun 7 |
1 |
| 32 |
28623290 | TCRP1 transcriptionally regulated by c-Myc confers cancer chemoresistance in tongue and lung cancer. | 2017 Jun 16 |
1 |
| 33 |
28817737 | Myc mediates cancer stem-like cells and EMT changes in triple negative breast cancers cells. | 2017 |
4 |
| 34 |
28878262 | Hyper-O-GlcNAcylation induces cisplatin resistance via regulation of p53 and c-Myc in human lung carcinoma. | 2017 Sep 6 |
3 |
| 35 |
29029460 | VRK1 promotes cisplatin resistance by up-regulating c-MYC via c-Jun activation and serves as a therapeutic target in esophageal squamous cell carcinoma. | 2017 Sep 12 |
3 |
| 36 |
29060932 | miR-34a increases cisplatin sensitivity of osteosarcoma cells in vitro through up-regulation of c-Myc and Bim signal. | 2017 Dec 12 |
3 |
| 37 |
29098029 | Synergistic anti-proliferative and pro-apoptotic activities of 5F and cisplatin in human non-small cell lung cancer NCI-H23 cells. | 2017 Nov |
1 |
| 38 |
29254192 | Inhibition of coiled coil domain containing protein 69 enhances platinum-induced apoptosis in ovarian cancer cells. | 2017 Nov 24 |
1 |
| 39 |
26392091 | Influence of selected anti-cancer drugs on the induction of DNA double-strand breaks and changes in gene expression in human hepatoma HepG2 cells. | 2016 Aug |
1 |
| 40 |
27110775 | Smad3 Sensitizes Hepatocelluar Carcinoma Cells to Cisplatin by Repressing Phosphorylation of AKT. | 2016 Apr 22 |
1 |
| 41 |
27492148 | PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer. | 2016 Aug 5 |
1 |
| 42 |
27765932 | Cisplatin-induced synthetic lethality to arginine-starvation therapy by transcriptional suppression of ASS1 is regulated by DEC1, HIF-1α, and c-Myc transcription network and is independent of ASS1 promoter DNA methylation. | 2016 Dec 13 |
2 |
| 43 |
25411027 | Sequential treatment with aurora B inhibitors enhances cisplatin-mediated apoptosis via c-Myc. | 2015 Apr |
5 |
| 44 |
25748238 | Erlotinib-cisplatin combination inhibits growth and angiogenesis through c-MYC and HIF-1α in EGFR-mutated lung cancer in vitro and in vivo. | 2015 Feb |
2 |
| 45 |
25796504 | Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin. | 2015 Apr |
4 |
| 46 |
26227489 | Targeting c-MYC in Platinum-Resistant Ovarian Cancer. | 2015 Oct |
4 |
| 47 |
24926545 | Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma. | 2014 Jul |
1 |
| 48 |
25131138 | C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells. | 2014 Dec |
5 |
| 49 |
23685757 | Effects of combined c-myc and Bmi-1 siRNAs on the growth and chemosensitivity of MG-63 osteosarcoma cells. | 2013 Jul |
1 |
| 50 |
23879689 | A role for the copper transporter Ctr1 in the synergistic interaction between hyperthermia and cisplatin treatment. | 2013 Sep |
1 |